This symposium explores the history of medications to treat obesity, the mechanisms of action of anti-obesity medications, pivotal studies of newer medications in adults and children, use of anti-obesity medications in clinical practice, and issues related to access to obesity treatment and health equity.
NIH Obesity Research Task Force Symposium:
Medications to Treat Obesity: Past, Present, and Future
01:30 Welcoming Remarks
Griffin P. Rodgers, M.D., M.A.C.P., Director, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
09:59 From Rainbow Pills to Polyagonists
Matthias Tschöp, M.D., Helmholtz Zentrum München
44:36 Mechanisms of Action of Incretin Drugs for Obesity
Randy Seeley, Ph.D., University of Michigan
1:18:58 Semaglutide for Treatment of Obesity in Adults
Domenica Rubino, M.D., Washington Center for Weight Management & Research
1:47:55 Tirzepatide for Treatment of Obesity and a Glimpse at the Pipeline
Ania Jastreboff, M.D., Ph.D., Yale University School of Medicine
2:20:28 Medications for Treatment of Obesity in Children and Adolescents
Jack Yanovski, M.D., Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development
2:50:27 Using Medications to Treat Obesity in Clinical Practice
Louis Aronne, M.D., Weill Cornell Medicine
3:21:21 Access to Obesity Treatment and Health Equity
Ihuoma Eneli, M.D., Children’s Hospital Colorado
3:53:53 Patient Perspectives
Moderator: Susan Yanovski, M.D., NIDDK
4:27:13 Panel Discussion
Moderator: Susan Yanovski, M.D., NIDDK
For more information, visit https://www.niddk.nih.gov/about-niddk...
Watch video NIH Obesity Research Task Force Symposium: Medications to Treat Obesity: Past, Present, and Future online, duration hours minute second in high quality that is uploaded to the channel National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 03 November 2023. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 2,628 times and liked it 43 visitors.